Rui Xu

Rui Xu

Auto-generated profile, based on publicly available information

Rui Xu

Jiangsu Co-Innovation Center for the Prevention and Control of Animal Infectious Disease and Zoonoses , College of Veterinary Medicine , Yangzhou University , Yangzhou , Jiangsu , 225009 , China , yzu.edu.cn

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
PDF file
JCJiao Cai
Jiao Cai
HPHongze Pang
Hongze Pang
RXRui Xu
Rui Xu
CMChenchen Meng
Chenchen Meng
SXShiyan Xu
Shiyan Xu
XZXiaorong Zhang
Xiaorong Zhang
In 2025, an infectious bronchitis virus (IBV) strain of the GVIII genotype was identified and isolated from a poultry farm in Hebei Province, China, representing the first documented detection of this IBV genotype within the country to date. Nucleotide homology analysis revealed that the S1 gene of this isolate shares 62.2%–96.9% sequence identity with previously reported GVIII‐type strains from other countries. Comprehensive phylogenetic analysis of the complete genome indicated that this strain originated from a single recombination event: Its S gene may have been derived from the GVIII‐1 lineage strain IBV/Ck/USA/CA/21‐1883, while the remaining genomic regions were likely acquired from the GI‐19 lineage strain SD. Pathogenicity evaluation demonstrated that infected flocks exhibited reduced body weight gain, with 40% of chickens showing signs of diarrhea. Necropsy findings included hemorrhagic lesions at the proventriculus‐gizzard junction and within the bursa of Fabricius. Moreover, 85% of infected hens developed severe oviduct hypoplasia, and 90% showed a reduction in follicular number. The isolate described in this study constitutes the first detection of a GVIII genotype IBV strain in China, although its route of introduction remains undetermined. The emergence of this strain highlights the necessity for sustained molecular surveillance of IBV and the development of genotype‐matched vaccines.